Inventor · disambiguated record
Betsy Herold
Also filed as: HEROLD BETSY · HEROLD BETSY C
11 granted patents·8 pending applications·6 citations·filing 2005–2025
83Inventor score
Files withALBERT EINSTEIN COLLEGE MEDICINE14ALBERT EINSTEIN COLLEGE MEDICINE INC2ALBERT EINSTEIN COLLGE OF MEDICINE INC1EINSTEIN COLL MED1SINAI SCHOOL MEDICINE1
Top patents by PatentIndex Score
19 records- 0179US11684670B2Methods of using HSV-2 single cycle virus delta-gD and HSV-2 recombinant glycoprotein DALBERT EINSTEIN COLLEGE MEDICINE·Filed 2021·Granted Jun 27, 2023·1 cites·30 claims
- 0279US9999665B2Recombinant herpes simplex virus 2 (HSV-2) vaccine vectorsALBERT EINSTEIN COLLEGE MEDICINE INC·Filed 2016·Granted Jun 19, 2018·2 cites·12 claims
- 0378US10918712B2Passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectorsALBERT EINSTEIN COLLEGE MEDICINE·Filed 2019·Granted Feb 16, 2021·1 cites·15 claims
- 0475US10076568B2Recombinant herpes simplex virus 2 (HSV-2) vaccine vectorsALBERT EINSTEIN COLLEGE MEDICINE INC·Filed 2017·Granted Sep 18, 2018·1 cites·21 claims
- 0573US10391165B2Recombinant herpes simplex virus 2 (HSV-2) vaccine vectorsALBERT EINSTEIN COLLGE OF MEDICINE INC·Filed 2018·Granted Aug 27, 2019·1 cites·4 claims
- 0672US10980874B2Recombinant herpes simplex virus 2 (HSV-2) vaccine vectorsALBERT EINSTEIN COLLEGE MEDICINE·Filed 2020·Granted Apr 20, 2021·0 cites·13 claims
- 0770US10751411B2Recombinant herpes simplex virus 2 (HSV-2) vaccine vectorsALBERT EINSTEIN COLLEGE MEDICINE·Filed 2019·Granted Aug 25, 2020·0 cites·9 claims
- 0865US12150986B2HSV-2-delta-gD vaccines and methods for their production and useALBERT EINSTEIN COLLEGE MEDICINE·Filed 2022·Granted Nov 26, 2024·0 cites·19 claims
- 0961US2025025473A1Cell impermeable kinase inhibitors to treat sars-cov-2 and/or hsv viral infectionsALBERT EINSTEIN COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 1060US2024352094A1Compositions and methods for the treatment of herpes simplex virus infectionALBERT EINSTEIN COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 1153US2023111803A1Method of treating and preventing ocular disease with hsv-2 delta gdALBERT EINSTEIN COLLEGE MEDICINE·Filed 2021·Application pending·0 cites
- 1253US2025276039A1Method of enhancing antibody-dependent cell-mediated cytotoxicity (adcc)ALBERT EINSTEIN COLLEGE MEDICINE·Filed 2025·Application pending·0 cites
- 1350US2021236625A1HSV-2-DELTA-gD VACCINES AND METHODS FOR THEIR PRODUCTION AND USEALBERT EINSTEIN COLLEGE MEDICINE·Filed 2019·Application pending·0 cites
- 1448US9333219B2Method to treat or prevent herpesvirus infectionsEINSTEIN COLL MED·Filed 2013·Granted May 10, 2016·0 cites·14 claims
- 1548US2022088185A1Passive transfer of immunity using recombinant herpes simplex virus 2 (hsv-2) vaccine vectorsALBERT EINSTEIN COLLEGE MEDICINE·Filed 2020·Application pending·0 cites
- 1648US2021361743A1Method of enhancing antibody-dependent cell-mediated cytotoxicity (adcc)ALBERT EINSTEIN COLLEGE MEDICINE·Filed 2019·Application pending·0 cites
- 1747US11382919B2Prevention and treatment of viral infectionsALBERT EINSTEIN COLLEGE MEDICINE·Filed 2018·Granted Jul 12, 2022·0 cites·18 claims
- 1844US2007232576A1Sulfated molecular umbrellas as anti-HIV and anti-HSV agentsSINAI SCHOOL MEDICINE·Filed 2005·Application pending·0 cites
- 1943US12459987B2Monoclonal antibodies for prevention and treatment of herpes simplex viral infectionsALBERT EINSTEIN COLLEGE MEDICINE·Filed 2020·Granted Nov 4, 2025·0 cites·27 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →